Castle Biosciences, Inc. logo CSTL - Castle Biosciences, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 11
HOLD 0
SELL 0
STRONG
SELL 0
| PRICE TARGET: $47.80 DETAILS
HIGH: $52.00
LOW: $40.00
MEDIAN: $50.00
CONSENSUS: $47.80
UPSIDE: 137.22%

Profitability Ratios

Ratio Value
GP Margin 79.4%
EBIT Margin -8.5%
EBITDA Margin 3.3%
Operating Margin -12.4%
Pretax Margin -8.6%
Cont. Ops Margin -7.0%
Net Margin -7.0%
Bottom Line Margin -7.0%

Liquidity Ratios

Ratio Value
Current Ratio 5.26
Quick Ratio 5.11
Solvency Ratio 0.154
Cash Ratio 1.70

Valuation Ratios

Ratio Value
Price/Earnings
-46.67
Hist. avg: 48.2
Peers avg: 31.5
PEG Ratio 0.21
Forward PEG 0.21
Price/Book 2.39
Price/Sales 3.28
Price/FCF 39.81
Price/Op Cash Flow 17.52

Debt Ratios

Ratio Value
Debt/Assets 0.0638
Debt/Equity 0.0784
Debt/Capital 0.0727
Long-Term Debt/Capital 0.0695
Financial Leverage 1.23

Cash Flow Ratios

Ratio Value
Working Capital Turnover 1.14
Operating Cash Flow Ratio 0.937
Operating Cash Flow/Sales 18.7%
Free Cash Flow/Operating Cash Flow 44.0%

Coverage Ratios

Ratio Value
Debt Service Coverage 9.14
Interest Coverage -497.7907
Short-Term Operating Cash Flow Coverage 36.94
Operating Cash Flow Coverage 1.74
Capital Expenditure Coverage 1.79
Dividend + Capital Expenditure Coverage 1.79

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 11.88
EPS -0.833
Debt/Share 1.2764
Cash/Share 10.33
Book Value/Share 16.24
Tangible BV/Share 12.81
Equity/Share 16.24
Operating Cash Flow/Share 2.220
Capital Expenditure/Share 1.243
FCF/Share 0.977

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 0.819
Earnings Before Tax/EBIT 0.689
Price/Fair Value 2.39
Debt/Market Cap 0.0327
Effective Tax Rate 18.1%
Enterprise Value Multiple 92.37